Lite Strategy, Inc. — Director's Dealing 2017

Nov 30, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MEI Pharma, Inc. (MEIP)
CIK: 0001262104
Period of Report: 2017-11-27

Reporting Person: Baltic Charles V. III (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-11-27	Common Stock, par value $0.00000002	S	11000	$2.2065	Disposed	13250	Direct
2017-11-27	Common Stock, par value $0.00000002	P	11000	$2.2546	Acquired	24250	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock, par value $0.00000002	5350	Indirect

Footnotes

F1: The shares sold by the reporting person are held through an Individual Retirement Account.

F2: The shares purchased by the reporting person are held through a brokerage account. Offsetting purchases and sales were conducted by the reporting person, with the purchase price exceeding the sales price, at no profit to the reporting person, for tax planning purposes.